Baxter Recall All Heparin as Death Toll Climbs

Baxter International has announced that it is taking all of its heparin supply off the market just as the FDA is reporting that the number of deaths associated with the bad heparin has risen from 4 to 21. The FDA has inspected the proper Chinese plant this time but still has not been able to determine the exact cause of the heparin problem. However, a redacted report from the FDA indicated the plant’s failure to properly follow the steps for identifying impurities and deficiencies related to manufacturing equipment.